Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The original Cell Metabolism discovery paper established that MOTS-c regulates insulin sensitivity through this pathway, and later work in Nature Communications by Reynolds et al
Zhang, J., et al
22 Target population did not align with the Health Canada indication
further reading Eli Lillys GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 (CNBC)
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
